Financhill
Sell
24

ARWR Quote, Financials, Valuation and Earnings

Last price:
$18.67
Seasonality move :
14.19%
Day range:
$18.10 - $19.41
52-week range:
$17.05 - $37.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.19x
P/B ratio:
12.41x
Volume:
2.5M
Avg. volume:
1.9M
1-year change:
-53.13%
Market cap:
$2.3B
Revenue:
$3.6M
EPS (TTM):
-$5.01

Earnings Data

Next earnings date for ARWR
Feb 06
2025
Most recent earnings per share
-$1.37
Missed by $0.45
(Nov 26/2024)
Consensus Estimate
-$0.92
(Nov 26/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARWR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $74.6M -- -- -$0.70 --
02/06/2025 Q4 $19.1M -- -- -$0.72 --
11/26/2024 Q3 $58.9M -- -$1.37 -$0.92 -$0.45
08/08/2024 Q2 $37.1M -- -$1.38 -$0.59 -$0.79
05/09/2024 Q1 $56.8M -- -$1.02 -$0.20 -$0.82
02/06/2024 Q4 $29.6M $3.6M -$1.24 -$0.83 -$0.41
11/29/2023 Q3 -- -- -$1.02 -$0.58 -$0.44
08/07/2023 Q2 -- -- -$0.96 -$0.53 -$0.43
05/02/2023 Q1 -- -- $0.45 -$0.59 $1.04
02/06/2023 Q4 -- -- -$0.39 $0.13 -$0.52
11/28/2022 Q3 -- -- -$0.81 -- --
08/04/2022 Q2 -- -- -$0.68 -- --
05/10/2022 Q1 -- -- $0.41 -- --
02/02/2022 Q4 -- -- -$0.60 -- --
11/22/2021 Q3 -- -- -$0.61 -- --
08/05/2021 Q2 -- -- -$0.29 -- --
05/04/2021 Q1 -- -- -$0.26 -- --
02/04/2021 Q4 -- -- -$0.20 -- --
11/23/2020 Q3 -- -- -$0.48 -- --
08/05/2020 Q2 -- -- -$0.13 -- --
05/07/2020 Q1 -- -- -$0.20 -- --
02/05/2020 Q4 -- -- -$0.03 -- --
11/25/2019 Q3 -- -- $0.11 -- --
08/05/2019 Q2 -- -- $0.21 -- --
05/08/2019 Q1 -- -- $0.24 -- --
02/07/2019 Q4 -- -- $0.13 -- --
12/11/2018 Q3 -- -- -$0.12 -- --
08/07/2018 Q2 -- -- -$0.18 -- --
05/08/2018 Q1 -- -- -$0.18 -- --
02/09/2018 Q4 -- -- -$0.18 -- --
12/12/2017 Q3 -- -- -$0.15 -- --
08/03/2017 Q2 -- -- -$0.07 -- --
05/03/2017 Q1 -- -- -$0.08 -- --
02/06/2017 Q4 -- -- -$0.17 -- --
12/14/2016 Q3 -- -- -$0.34 -- --
08/09/2016 Q2 -- -- -$0.32 -- --
05/10/2016 Q1 -- -- -$0.35 -- --
02/09/2016 Q4 -- -- -$0.32 -- --
12/14/2015 Q3 -- -- -$0.41 -- --
08/04/2015 Q2 -- -- -$0.27 -- --
05/11/2015 Q1 -- -- -$0.51 -- --

Arrowhead Pharmaceuticals Earnings Questions

  • How Much did Arrowhead Pharmaceuticals Generate in Revenue Last Quarter?

    Arrowhead Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Arrowhead Pharmaceuticals Beat Earnings Last Quarter?

    Arrowhead Pharmaceuticals announced earnings per share of -$1.37 which represents a miss of analyst forecast a -$0.92 per share.

  • Is Arrowhead Pharmaceuticals Profitable?

    Arrowhead Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Arrowhead Pharmaceuticals EPS Next Year?

    Arrowhead Pharmaceuticals's earnings are forecast to decrease from -$5.00 per share to -$4.53 per share next year representing a decrease of -17.33%.

  • When is Arrowhead Pharmaceuticals's Earnings Date?

    Arrowhead Pharmaceuticals's next earnings date is February 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Buffett Sell So Much Last Year?
Why Did Buffett Sell So Much Last Year?

In 2024, value investing legend Warren Buffett did the seemingly…

Is American Tower Stock Undervalued?
Is American Tower Stock Undervalued?

The market action of late has been nothing short of…

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 13

Constellation Energy [CEG] is down 8.54% over the past day.

Sell
1
MCY alert for Jan 13

Mercury General [MCY] is down 2.86% over the past day.

Buy
84
ATZAF alert for Jan 13

Aritzia [ATZAF] is down 4.41% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock